Blocking Oxytocin Receptors Does Not Trigger Migraine Attacks in Clinical Trial | Research

The takeaway

Acute oxytocin receptor blockade with atosiban did not trigger migraine in women or men with migraine, suggesting oxytocin acts as a modulator rather than a direct migraine driver.

No migraine trigger
Blocking oxytocin receptors did not provoke migraine attacks in women or men with migraine vs placebo

What the researchers found

Atosiban did not increase migraine-like attacks vs placebo in women with migraine (30% vs 20%, p=0.75), healthy controls (0% vs 0%), or men with migraine (10% vs 15%, p>0.999). Vascular changes occurred in controls but not migraine patients.

Why it matters

Understanding that oxytocin blockade doesn't trigger migraine clarifies its role in the disease and informs therapeutic strategy—intranasal oxytocin may work through modulation rather than correcting a deficiency.

How the study worked

Randomized, double-blind, placebo-controlled, crossover study in 60 participants (20 WM, 20 HC, 20 MM) receiving atosiban IV or placebo, with 12-hour observation for migraine attacks and vascular measurements.

What this study cannot tell us

Atosiban is short-acting and may not penetrate the brain significantly. Stable hormonal conditions (continuous contraception) may not reflect natural hormonal fluctuations. Three-hour infusion may be insufficient.

How to read the evidence

Well-designed RCT (double-blind, placebo-controlled, crossover) with three participant groups. Definitive for the short-acting blockade question.

When this study was published

Published in 2025, registered DRKS00033341.

The bigger picture

This is the first RCT to test whether disrupting oxytocin signaling triggers migraine, providing crucial evidence for understanding oxytocin's role in headache disorders.

Questions still open

Would a longer-acting or brain-penetrant oxytocin antagonist produce different results?
Does oxytocin modulate migraine susceptibility during hormonal fluctuations?
Could oxytocin agonists (rather than antagonists) be therapeutic for migraine prevention?

Common questions

Does oxytocin cause or prevent migraines?

This study shows that blocking oxytocin doesn't trigger migraines, suggesting it's not a direct cause. Instead, oxytocin likely acts as a modulator that influences migraine susceptibility through complex interactions with other systems like CGRP.

Could oxytocin be used to treat migraines?

The role of oxytocin in migraine is still being clarified. This study suggests it acts as a modulator rather than a simple on/off switch. Intranasal oxytocin has been explored for migraine but results have been mixed.

Read the original research

Oxytocin receptor antagonism in migraine: a randomized, double-blind, placebo-controlled provocation study.

The journal of headache and pain, 27(1)

View on PubMed ↗Publisher’s paper ↗

Citation

Fitzek, Mira Pauline; Kleist, Paula; Handtmann, Cleo; Overeem, Lucas Hendrik; Hoehne, Carolin Luisa; Lange, Kristin Sophie; Angerhöfer, Cornelius; Salim, Yones; Ebert, Andreas D; Mattern, Nicole; Reuter, Uwe; Raffaelli, Bianca. (2026). Oxytocin receptor antagonism in migraine: a randomized, double-blind, placebo-controlled provocation study.. The journal of headache and pain, 27(1). https://doi.org/10.1186/s10194-026-02297-z